Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-03-31

Clinical Trial Update: Gold Against Pains From Osteoarthrosis in the Knee [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gold for knee osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gold

Snippet

Sponsor: Northern Orthopaedic Division, Denmark | Conditions: Arthritis | Phase 2 | Status: WITHDRAWN